New York State Common Retirement Fund Cidara Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.48 - $2.35 $418 - $665	-283 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$1.87 - $2.7 $66,420 - $95,901	-35,519 Reduced 99.21%	283 $1,000
Q1 2021 May 11, 2021	SELL	$2.06 - $3.01 $73,727 - $107,727	-35,790 Reduced 49.99%	35,802 $95,000
Q4 2020 Feb 08, 2021	SELL	$1.99 - $3.25 $1,691 - $2,762	-850 Reduced 1.17%	71,592 $143,000
Q2 2020 Aug 07, 2020	BUY	$2.39 - $4.0 $73,134 - $122,400	30,600 Added 73.13%	72,442 $267,000
Q1 2020 May 06, 2020	BUY	$1.74 - $4.26 $14,428 - $35,323	8,292 Added 24.72%	41,842 $104,000
Q3 2019 Nov 07, 2019	BUY	$1.25 - $2.35 $6,050 - $11,374	4,840 Added 16.86%	33,550 $67,000
Q2 2019 Aug 09, 2019	SELL	$1.49 - $2.94 $2,518 - $4,968	-1,690 Reduced 5.56%	28,710 $48,000
Q1 2019 May 08, 2019	SELL	$2.35 - $3.27 $4,817 - $6,703	-2,050 Reduced 6.32%	30,400 $81,000
Q4 2018 Feb 08, 2019	SELL	$2.1 - $4.5 $3,045 - $6,525	-1,450 Reduced 4.28%	32,450 $76,000
Q2 2018 Aug 10, 2018	BUY	$3.75 - $6.05 $127,125 - $205,095	33,900 New	33,900 $176,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.